Overcoming Hormone Therapy Resistance in Metastatic Breast Cancer
An expert discusses the next steps for patients with metastatic breast cancer after their disease no longer responds to hormone therapy.
Watch
Jemperli-Chemo Regimen Shows Survival Promise in Advanced NSCLC
In patients with advanced NSCLC, treatment with Jemperli plus chemotherapy showed promising effectiveness compared with Keytruda plus chemotherapy.
Read More
Common Prostate Cancer Radiation Questions Answered
Expert answers to patients’ questions were offered as part of the CURE® Educated Patient® Prostate Cancer Summit.
Balancing Decisions Around Breast Cancer Treatment and Fertility, Breastfeeding
An expert discussed how patients with breast cancer, particularly those with a BRCA mutation, should consider future fertility and breastfeeding when making treatment decisions.
Monitoring Treatment With Different Types of Biopsies in Lung Cancer
An expert discussed how liquid and tissue biopsies can help monitor treatment and detect potential resistance in patients with non-small cell lung cancer.
Regular Check-Ups Provide Necessary Support During Breast Cancer Survivorship
Through regular follow-ups and symptom assessments, breast cancer survivors have the access to physical and emotional support they may need.
Discussing Radiation as a Treatment Option for Kidney Cancer
An expert explained the advantages and disadvantages of radiation as a treatment for patients with renal cell carcinoma, a type of kidney cancer.
Treatment Side Effects, Quality of Life Factors in Prostate Cancer
It’s crucial for patients with prostate cancer to know that all treatments come with side effects, which may affect their quality of life.
Rise in PSA Levels May Predict Treatment Response in Prostate Cancer
The rate at which PSA rises after hormonal therapy for prostate cancer is a key factor in determining the effectiveness of the treatment.
‘Not Enough to Say Breast Cancer’ When Discussing Diagnoses, Expert Says
An expert discussed the importance of patients learning about their specific type of breast cancer to understand potential treatment options.
Resistance Mechanisms May Steer Therapy Sequences in EGFR-Mutated Lung Cancer
An expert discussed how the understanding of resistance mechanisms can help care teams develop a global treatment strategy for EGFR-mutated non-small cell lung cancer.
Focal Therapy May Reduce Side Effects, Improve Quality of Life in Prostate Cancer
With approaches like high intensity focused ultrasound, patients with prostate cancer may experience lower rates of urinary incontinence and erectile dysfunction, an expert said.
Next-Generation Imaging a ‘Gold Standard’ in Metastatic Prostate Cancer
Patients with metastatic prostate cancer may have improved survival outcomes after undergoing next-generation PSMA PET imaging, an expert explained.
Fertility Preservation Options for Young Patients With Breast Cancer
An expert discussed options young patients with breast cancer may have to preserve their fertility before starting cancer treatment.
Why ‘Genetic Testing is Critical’ in Patients with Prostate Cancer
As part of the CURE® Educated Patient® Prostate Cancer Summit, an expert discussed the role genetic testing plays in treatment decision-making for many.
Biomarkers Guide Treatment for Metastatic Breast Cancer
An expert discussed the importance of biomarkers in guiding treatment decisions for patients with metastatic breast cancer.
Transurethral Ultrasound Ablation a Promising Prostate Cancer Treatment
TULSA is a targeted prostate cancer treatment that uses ultrasound to destroy tumors while preserving healthy tissue.
Managing Symptoms, Controlling Disease With Radiation in Kidney Cancer
An expert explained how radiation may be a treatment option for patients with renal cell carcinoma to manage symptoms and control the disease.
Rybrevant Plus Chemotherapy May Improve PFS for Relapsed EGFR Lung Cancer
The drug combined with chemotherapy demonstrated a 60% increase in progression-free survival, suggesting signs of an FDA approval.
High vs Low Dose of Vitamin D May Not Impact Treating mCRC
For patients with metastatic colorectal cancer, adding a higher dose proves just as effective as the standard dose of vitamin D3, despite one exception.
Non-Surgical Options May Maintain Relapse-Free Survival in Rectal Cancer Subset
Distance relapse-free survival was maintained in patients with pMMR locally advanced rectal cancer through non-operative management of the disease.
Perioperative Opdivo Extends Event-Free Survival in Lung Cancer
Receiving perioperative Opdivo for non-small cell lung cancer showed event-free survival benefits compared with placebo.
Herceptin, Perjeta Regimen May Be Effective Without Chemo in Breast Cancer
Among patients with HR+/HER2+ breast cancer, Herceptin and Perjeta plus endocrine therapy proved to be beneficial without chemotherapy.
Long-Term Study Data Support Keytruda as Standard of Care for Advanced Melanoma
Keytruda continued to improve survival versus Yervoy in unresectable stage 3 or 4 melanoma in long-term follow-up data.
Anti-PD-L1 Antibody Drug Combo May Improve Outcomes in Advanced Kidney Cancer
Benmelstobart plus anlotinib significantly improved survival versus Sutent in the first-line treatment of advanced renal cell carcinoma.
Lower Keytruda Doses May Be as Effective as Standard Doses for Stage 4 NSCLC
Patients with stage 4 non-small cell lung cancer may derive an equal benefit with a lower dose of Keytruda versus the standard dose.
Side Effects, Quality of Life Important to Consider in Breast Cancer Subset
Patients with HER2-positive metastatic breast cancer may consider related side effects and quality of life outcomes when choosing treatments.
Cediranib Added to Lynparza Didn’t Improve Progression, Survival in Ovarian Cancer
A Lynparza/cediranib combo had similar results versus standalone Lynparza among patients with relapsed platinum-sensitive ovarian cancer.
Kidney Cancer Questions Answered, From Protein Intake to Clinical Trials
An expert provides answers to readers’ questions regarding different aspects of the kidney cancer experience, such as protein intake and clinical trials.
Imjudo Plus Imfinzi Improve Survival Versus Nexavar in Liver Cancer
In patients with unresectable liver cancer, treatment with Imjudo plus Imfinzi showed better survival outcomes compared with Nexavar.
